NO20055923L - Farmasoytisk anvendbare salter av karboksylsyrderivater - Google Patents
Farmasoytisk anvendbare salter av karboksylsyrderivaterInfo
- Publication number
- NO20055923L NO20055923L NO20055923A NO20055923A NO20055923L NO 20055923 L NO20055923 L NO 20055923L NO 20055923 A NO20055923 A NO 20055923A NO 20055923 A NO20055923 A NO 20055923A NO 20055923 L NO20055923 L NO 20055923L
- Authority
- NO
- Norway
- Prior art keywords
- carboxylic acid
- acid derivatives
- pharmaceutically usable
- usable salts
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Et kalsium- eller magnesiumsalt av (2S)-2-etoksy-3-(4-{2-[heksyl(2-fenyletyl)amino]-2- oksoetoksy } fenyl)propansyre.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0314136.3A GB0314136D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
PCT/SE2004/000965 WO2004110985A1 (en) | 2003-06-18 | 2004-06-16 | Pharmaceutically useful salts of carboxylic acid derivates |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20055923L true NO20055923L (no) | 2006-01-06 |
Family
ID=27636795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055923A NO20055923L (no) | 2003-06-18 | 2005-12-13 | Farmasoytisk anvendbare salter av karboksylsyrderivater |
Country Status (21)
Country | Link |
---|---|
US (1) | US20060194879A1 (no) |
EP (1) | EP1638921A1 (no) |
JP (1) | JP3836498B1 (no) |
KR (1) | KR20060017646A (no) |
CN (1) | CN1805922A (no) |
AR (1) | AR044802A1 (no) |
AU (1) | AU2004247611A1 (no) |
BR (1) | BRPI0411455A (no) |
CA (1) | CA2527608A1 (no) |
CO (1) | CO5650229A2 (no) |
GB (1) | GB0314136D0 (no) |
IL (1) | IL172168A0 (no) |
IS (1) | IS8232A (no) |
MX (1) | MXPA05013713A (no) |
NO (1) | NO20055923L (no) |
RU (1) | RU2005138369A (no) |
SA (1) | SA04250170B1 (no) |
TW (1) | TW200503678A (no) |
UY (1) | UY28371A1 (no) |
WO (1) | WO2004110985A1 (no) |
ZA (1) | ZA200510199B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
GB0229931D0 (en) * | 2002-12-21 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0314079D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
DE60319084T2 (de) | 2002-06-20 | 2009-01-29 | Astrazeneca Ab | Ortho-substituierte benzoesäurederivate zur behandlung von insulinresistenz |
WO2007004957A1 (en) * | 2005-07-05 | 2007-01-11 | Astrazeneca Ab | Novel crystalline form |
AR055073A1 (es) * | 2005-07-11 | 2007-08-01 | Astrazeneca Ab | Agentes terapeuticos |
FR2903985B1 (fr) | 2006-07-24 | 2008-09-05 | Sanofi Aventis Sa | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
FR2904316B1 (fr) | 2006-07-31 | 2008-09-05 | Sanofi Aventis Sa | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique. |
UY30648A1 (es) * | 2006-10-20 | 2008-05-02 | Janssen Pharmaceutica Nv | Formas salinas de compuestos de benzotienilo sustituido |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1208323C (zh) * | 1999-04-06 | 2005-06-29 | 三共株式会社 | α-取代羧酸衍生物 |
SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
-
2003
- 2003-06-18 GB GBGB0314136.3A patent/GB0314136D0/en not_active Ceased
-
2004
- 2004-06-09 TW TW093116599A patent/TW200503678A/zh unknown
- 2004-06-16 CN CNA2004800168384A patent/CN1805922A/zh active Pending
- 2004-06-16 JP JP2006517040A patent/JP3836498B1/ja not_active Expired - Fee Related
- 2004-06-16 MX MXPA05013713A patent/MXPA05013713A/es not_active Application Discontinuation
- 2004-06-16 BR BRPI0411455-8A patent/BRPI0411455A/pt not_active IP Right Cessation
- 2004-06-16 EP EP04736956A patent/EP1638921A1/en not_active Withdrawn
- 2004-06-16 KR KR1020057024066A patent/KR20060017646A/ko not_active Application Discontinuation
- 2004-06-16 US US10/560,127 patent/US20060194879A1/en not_active Abandoned
- 2004-06-16 SA SA04250170A patent/SA04250170B1/ar unknown
- 2004-06-16 CA CA002527608A patent/CA2527608A1/en not_active Abandoned
- 2004-06-16 RU RU2005138369/04A patent/RU2005138369A/ru not_active Application Discontinuation
- 2004-06-16 AU AU2004247611A patent/AU2004247611A1/en not_active Abandoned
- 2004-06-16 WO PCT/SE2004/000965 patent/WO2004110985A1/en active Application Filing
- 2004-06-17 AR ARP040102112A patent/AR044802A1/es not_active Application Discontinuation
- 2004-06-17 UY UY28371A patent/UY28371A1/es not_active Application Discontinuation
-
2005
- 2005-11-24 IL IL172168A patent/IL172168A0/en unknown
- 2005-12-13 NO NO20055923A patent/NO20055923L/no not_active Application Discontinuation
- 2005-12-14 ZA ZA200510199A patent/ZA200510199B/en unknown
- 2005-12-28 CO CO05130776A patent/CO5650229A2/es unknown
-
2006
- 2006-01-13 IS IS8232A patent/IS8232A/is unknown
Also Published As
Publication number | Publication date |
---|---|
AR044802A1 (es) | 2005-10-05 |
UY28371A1 (es) | 2005-01-31 |
IS8232A (is) | 2006-01-13 |
JP2006527767A (ja) | 2006-12-07 |
JP3836498B1 (ja) | 2006-10-25 |
WO2004110985A1 (en) | 2004-12-23 |
EP1638921A1 (en) | 2006-03-29 |
AU2004247611A1 (en) | 2004-12-23 |
CO5650229A2 (es) | 2006-06-30 |
TW200503678A (en) | 2005-02-01 |
MXPA05013713A (es) | 2006-06-27 |
CA2527608A1 (en) | 2004-12-23 |
KR20060017646A (ko) | 2006-02-24 |
GB0314136D0 (en) | 2003-07-23 |
CN1805922A (zh) | 2006-07-19 |
ZA200510199B (en) | 2006-12-27 |
US20060194879A1 (en) | 2006-08-31 |
RU2005138369A (ru) | 2007-07-27 |
BRPI0411455A (pt) | 2006-07-18 |
SA04250170B1 (ar) | 2007-10-29 |
IL172168A0 (en) | 2009-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055923L (no) | Farmasoytisk anvendbare salter av karboksylsyrderivater | |
NO20055922L (no) | Farmasoytiske anvendbare salter av karboksylsyrderivater | |
CY1124753T1 (el) | Συνθεση ενωσεων βορονικων εστερων και οξεων | |
CR8218A (es) | Antidoto sobre la base de derivados de acidos carboxilicos aromaticos alifaticos | |
ATE469674T1 (de) | 5-aminolävulinsäure-derivate zur behandlung von akne | |
CR20120526A (es) | Proceso para la preparación de 4-{4[({[4-cloro-3-(trifluorometilo)-fenilo] amino} carbonilo) amino]-3-fluorofenoxi}-n-metilpiridino-2-carboxamida, sus sales y monohidrato | |
MA29416B1 (fr) | Inhibiteurs d'age | |
DE602004024545D1 (de) | Indungen | |
MY148953A (en) | Substituted biphenyl carboxylic acids and derivatives thereof | |
NO20073755L (no) | Ibandronatpolymorf B | |
PL362366A1 (en) | New method of industrial synthesis of tetra esters of 5-[bis(carboxyl methyl)amino]-3 -karboxymethyl-4-cyano-2-tio phenokarboxylic acid, method of manufacture of divalent salts of ranelic acid and their hydrates, as well as new intermediate compounds | |
EA200900707A1 (ru) | Новый способ синтеза 7,8-диметокси-1,3-дигидро-2h-3-бензазепин-2-она, и его применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
RS52108B (en) | 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS | |
CY1111881T1 (el) | Υδατικη φαρμακοτεχνικη μορφη του 4-[((4-καρβοξυβουτυλο)-{2-[(4-φαιναιθυλο-βενζυλο)οξυ]φαιναιθυλο}-αμινο)μεθυλο]βενζοϊκου οξεος | |
DE502006009412D1 (de) | Matrixkontrolliertes transdermales system mit salzen der ace-hemmer-dicarbonsäuren | |
DE60326720D1 (de) | Sulfonsäuresalze von Mandelsäurederivaten | |
SE0403072D0 (sv) | Pharmaceutically useful salts of carboxylic acid derivates | |
EA200701925A1 (ru) | Способ получения энантиомерночистых e-2(s)-алкил-5-галопент-4-еновых кислот и их сложных эфиров | |
ATE438611T1 (de) | Verfahren zum herstellen von racemischem 3- hydroxy-3-(2-phenylethyl)-hexansäureester | |
TH81758A (th) | เกลือของอนุพันธ์คาร์บอกซิลิคแอซิดที่มีประโยชน์ในทางเภสัชกรรม | |
NO20091308L (no) | Framgangsmate | |
TH69770A (th) | สารรักษาโรค | |
FI20021510A (fi) | Karboksyylihapon suolojen valmistusprosessi | |
ITMI20031326A0 (it) | Sali di acidi idrossicinnamici e di idrossistilbeni otticamente attivi | |
ATE380783T1 (de) | Radiosynthese von säurechloriden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |